ALDER BIOPHARMACEUTICALS INC 4
4 · ALDER BIOPHARMACEUTICALS INC · Filed Sep 28, 2015
Insider Transaction Report
Form 4
Benedict Larry
Sr. VP Finance
Transactions
- Exercise/Conversion
Common Stock
2015-09-24$3.46/sh+10,437$36,164→ 26,247 total - Exercise/Conversion
Common Stock
2015-09-24$0.99/sh+5,454$5,399→ 6,720 total - Exercise/Conversion
Common Stock
2015-09-24$4.46/sh+9,090$40,496→ 15,810 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-09-24−5,454→ 0 totalExercise: $0.99Exp: 2019-04-20→ Common Stock (5,454 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2015-09-24−9,090→ 0 totalExercise: $4.46Exp: 2020-02-25→ Common Stock (9,090 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2015-09-24−10,437→ 7,744 totalExercise: $3.46Exp: 2022-06-12→ Common Stock (10,437 underlying)
Footnotes (2)
- [F1]The option is fully vested.
- [F2]The shares subject to this option vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of the vesting commencement date and 1/48th of the total number of shares each monthly anniversary of the vesting commencement date thereafter, for so long as the recipient of the option provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.